Ledger.Open graph →
SEC Form D · filed August 15, 2017

Synereca Pharmaceuticals, Inc

Offering
$1.2M
Sold
$600K
Exemption
Rule 506(b)
Industry
Other Health Care
Location
OKLAHOMA CITY, OK
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Clayton I. Duncan · Chapel Hill, NCExec · DirectorBennett W. Love · Oklahoma City, OKDirectorClayton I. Duncan · Oklahoma City, OKExec · DirectorScott F. Singleton · Oklahoma City, OKDirectorMark I. Corrigan · Oklahoma City, OKDirectorRichard E. Gammans · Oklahoma City, OKExec · PromoterScott I. Meacham · Oklahoma City, OKDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗